Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 8/20 | 0.49 |
| ▸ | PPARA | Q07869 | 8/20 | 0.49 |
| ▸ | PPARD | Q03181 | 2/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.36 |
| ▸ | BCL9 | O00512 | 1/20 | 0.36 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6363524 | 0.91 | PPARG (0.52) | PPARGPPARAPPARDRIPK1BCL9 | |
| SCHEMBL6359444 | 0.90 | PPARA (0.57) | PPARGPPARAPPARDCYP2D6 | |
| SCHEMBL7596460 | 0.89 | PPARA (0.58) | PPARGPPARAPPARDCYP2D6 | |
| SCHEMBL6358170 | 0.87 | PPARG (0.49) | PPARGPPARAPPARDRIPK1CYP2D6 | |
| SCHEMBL6359776 | 0.86 | PPARA (0.46) | PPARGPPARAPPARDRIPK1BCL9 | |
| SCHEMBL6363205 | 0.83 | PPARG (0.46) | PPARGPPARAPPARDRIPK1BCL9 | |
| SCHEMBL6357777 | 0.83 | PPARA (0.46) | PPARGPPARAPPARDRIPK1CYP2D6 | |
| SCHEMBL6363391 | 0.82 | PPARA (0.60) | PPARGPPARAPPARDCYP2D6 | |
| SCHEMBL6363503 | 0.81 | PPARA (0.61) | PPARGPPARAPPARDCYP2D6 | |
| SCHEMBL6358999 | 0.81 | PPARA (0.61) | PPARGPPARAPPARDCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050075377-A1 | PPAR compounds | PFIZER INC | 2005-04-07 | — | — | US | disclosed |
| US-20020169192-A1 | PPAR compounds | HAYWARD CHERYL M (US) | 2002-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020169192-A1 | PPAR compounds | PPARA, PPARG, PPARD | PPARG 2/4885PPARA 1/4885PPARD 3/4885 |
| US-20050075377-A1 | PPAR compounds | PPARA, PPARG, PPARD | PPARG 2/4885PPARA 1/4885PPARD 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.